Patent · US Active

EGFR dimer disruptors and use of the same

US11999731B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 9, 2022
Grant dateJun 4, 2024
Priority date—
Expiry dateMay 29, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/84
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are compounds that modulate EGFR and methods of using the same, for example to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.